March 23rd update on curves, data via John Burn-Murdoch Financial Times 1. US Deaths curve continues on a very steep course, about to hit Iran 2. New city/region map shows the severe slope in Madrid, emerging as worst fatality region (note NYC, it's early but an especially worrisome look)

Look what's 'currently trending' in the IJE! 😱 Thanks so much to everyone who's been reading and sharing! 😊 #EpiTwitter #CausalTwitter #DagReview academic.oup.com/journals/pages…

Thrilled to be here at UF! This is a place full of great mentors, colleagues and science. Can’t be happier Jonathan Licht, MD Thomas George, MD, FACP, FASCO Merry-Jennifer Markham, MD, FACP, FASCO Martina Murphy, MD ilyas sahin, MD @SheriOncMD

Dr. Melissa Lumish MD presenting IMPRESSIVE 100% clinical CR with IO alone for locally advanced #rectalcancer. 🚫 No chemo 🚫 No RT ✅ Just Nivo While only <5% of the patient population, whoa...... Confirmatory studies ongoing Kristen Ciombor Dr. Cathy Eng #crcsm #GI22

Thanks Pashtoon Kasi MD, MS! #GI22 NRG Oncology

Cobra #GI22 NRG Oncology ASCO Thomas George, MD, FACP, FASCO #colorectalcancer

#colorectalcancer NRG Oncology #GI22 ASCO Thomas George, MD, FACP, FASCO UF Health Cancer Institute

#colorectalcancer #MSI-H NRG Oncology #GI22 ASCO

#colorectalcancer #immunotherapy NRG Oncology ASCO #GI22

Rapid Assessment of #ctDNA in #colorectalcancer Natera Oncology #GI22 ASCO UF Health Cancer Institute

Neoadjuvant Chemotherapy with Nal-IRI in #PancreaticCancer giselle reyes ASCO @IpsenUS UF Health Cancer Institute

GI Oncology ⁦⁦UF Health Cancer Institute⁩. An All- Star team here. ⁦Thomas George, MD, FACP, FASCO⁩ ⁦Brian Ramnaraign, MD⁩ ⁦Jesus C Fabregas MD, MPH, FACP⁩ ⁦ilyas sahin, MD⁩ ⁦@SheriOncMD⁩

Important insights from ilyas sahin, MD Mohamed E. Salem, MD, FASCO about the management of patients with metastatic gastroesophageal cancers and low CPS score. Effect modification at its best.

Honored to be involved with NRG Oncology and NSABP Foundation in developing the next generation of #ColorectalCancer ctDNA trials that will change practice. #ChallengeAccepted ✅NRG-GI005 (COBRA) ✅NRG-GIOO8 (CIRCULATE-US) ✅NSABP FC-12 #ASCO22

Making strides in the research about #PancreaticCancer cancer ASCO #ASCO22. Feels great to be able to share. UF Health Cancer Institute Thomas George, MD, FACP, FASCO Brian Ramnaraign, MD Jesus C Fabregas MD, MPH, FACP ilyas sahin, MD

#ASCO22 ✳️Happy to say there is great progress for patients with CRC‼️ OncoAlert ASCO Manju George MVSc PhD Rectal Cancer Survivor CRC Change‼️ Here is summary of some key studies 👇

Everything you would want to know about management of colon cancer to complement #ASCO22 Thomas George, MD, FACP, FASCO Brian Ramnaraign, MD UF Health Cancer Institute CLINICAL UPDATES FOR COLON CANCER CARE IN 2022 clinical-colorectal-cancer.com/article/S1533-…

How do people w/ #crohnsdisease get arthritis? A gut #microbiome pathosymbiont implicated stm.sciencemag.org/content/9/376/… Weill Cornell Medicine Science Translational Medicine

FDA Grants #atezolizumab Approval as 1st line metastatic #bladdercancer joaquim bellmunt @MattGalsky Petros Grivas finance.yahoo.com/news/fda-grant…

"Japanese Phase II Trial of Nivolumab in Previously Treated Advanced Esophageal Cancer" ascopost.com/News/52451?pla… via The ASCO Post